Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells

✍ Scribed by Petra Maria Bertilsson; Patrik Olsson; Karl-Eric Magnusson

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 182 KB
• Volume: 90
• Category: Article
• ISSN: 0022-3549
• DOI: 10.1002/1520-6017(200105)90:5<638::aid-jps1020>3.0.co;2-l

✦ Synopsis

Inflammation and infection may have the potential to increase the bioavailability of drugs. This effect could be because of a reduced metabolism of xenobiotics in the liver and/or the intestines, or because of alterations in small intestinal permeability, mucosal flow, and expression of drug efflux transporters such as P-glycoprotein (Pgp). To assess the impact on intestinal epithelium of some proinflammatory cytokines and macrophages on permeability and mRNA expression of CYP3A4 and MDRI (multidrug resistance, coding for Pgp), we used the Caco-2 cell line as a model. Exposure to proinflammatory cytokines and macrophages decreased the mRNA expression of CYP3A4 and increased the expression of MDR1 mRNA in the Caco-2 cells. In parallel, the cell layer permeability, as measured by sodium fluorescein flux, increased for all cytokine and macrophage treatments, whereas the effect on transepithelial electrical resistance (TEER) varied. Our findings suggest that inflammation and infection trigger several different cellular responses that may affect drug bioavailability; that is hampered CYP3A4 expression, increased permeability of the epithelial cell layer, and enhanced Pgp-mediated counteractive transport.